Alzamend Neuro Ownership 2024 | Who Owns Alzamend Neuro Now?

Overview RevenueFinancials Chart

Institutional Ownership

6.35%

Insider Ownership

24.22%

Retail Ownership

69.43%

Institutional Holders

24.00

Alzamend Neuro Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-49	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-495	-100.00%	-	Dec 31, 2023
NORTHERN TRUST CORP	-	-	-	-103,775	-100.00%	-	Dec 31, 2023
TRUIST FINANCIAL CORP	-	-	-	-2,314,907	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-31,900	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-2,035,253	-100.00%	-	Dec 31, 2023
FMR LLC	-	-	-	-268	-100.00%	-	Dec 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	-	-	-	-53,080	-100.00%	-	Dec 31, 2023
MORGAN STANLEY	-	-	-	-500	-100.00%	-	Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-21,400	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-636,010	-100.00%	-	Dec 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-27,629	-100.00%	-	Dec 31, 2023
BLACKROCK INC.	-	-	-	-596,129	-100.00%	-	Dec 31, 2023
BANK OF NEW YORK MELLON CORP	-	-	-	-40,367	-100.00%	-	Dec 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-28,156	-100.00%	-	Dec 31, 2023
HARBOR INVESTMENT ADVISORY, LLC	-	-	-	-3,000	-100.00%	-	Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-48,605	-100.00%	-	Dec 31, 2023
UBS GROUP AG	-	-	-	-7,927	-100.00%	-	Dec 31, 2023
RFG ADVISORY, LLC	-	-	-	-250,000	-100.00%	-	Dec 31, 2023
IFP ADVISORS, INC	-	-	-	-5,000	-100.00%	-	Dec 31, 2023

Alzamend Neuro's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-49	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-495	-100.00%	-	Dec 31, 2023
NORTHERN TRUST CORP	-	-	-	-103,775	-100.00%	-	Dec 31, 2023
TRUIST FINANCIAL CORP	-	-	-	-2,314,907	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-31,900	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-2,035,253	-100.00%	-	Dec 31, 2023
FMR LLC	-	-	-	-268	-100.00%	-	Dec 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	-	-	-	-53,080	-100.00%	-	Dec 31, 2023
MORGAN STANLEY	-	-	-	-500	-100.00%	-	Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-21,400	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-636,010	-100.00%	-	Dec 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-27,629	-100.00%	-	Dec 31, 2023
BLACKROCK INC.	-	-	-	-596,129	-100.00%	-	Dec 31, 2023
BANK OF NEW YORK MELLON CORP	-	-	-	-40,367	-100.00%	-	Dec 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-28,156	-100.00%	-	Dec 31, 2023
HARBOR INVESTMENT ADVISORY, LLC	-	-	-	-3,000	-100.00%	-	Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-48,605	-100.00%	-	Dec 31, 2023
UBS GROUP AG	-	-	-	-7,927	-100.00%	-	Dec 31, 2023
RFG ADVISORY, LLC	-	-	-	-250,000	-100.00%	-	Dec 31, 2023
IFP ADVISORS, INC	-	-	-	-5,000	-100.00%	-	Dec 31, 2023

The largest Alzamend Neuro shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Alzamend Neuro (ALZN), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
JPMORGAN CHASE & CO	-	-	-	-49	-100.00%	-	Dec 31, 2023
FMR LLC	-	-	-	-268	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-495	-100.00%	-	Dec 31, 2023
MORGAN STANLEY	-	-	-	-500	-100.00%	-	Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-1,000	-100.00%	-	Dec 31, 2023
HARBOR INVESTMENT ADVISORY, LLC	-	-	-	-3,000	-100.00%	-	Dec 31, 2023
IFP ADVISORS, INC	-	-	-	-5,000	-100.00%	-	Dec 31, 2023
UBS GROUP AG	-	-	-	-7,927	-100.00%	-	Dec 31, 2023
INSIGHT WEALTH STRATEGIES, LLC	-	-	-	-10,000	-100.00%	-	Dec 31, 2023
XTX TOPCO LTD	-	-	-	-12,974	-100.00%	-	Dec 31, 2023
FOUNDATIONS INVESTMENT ADVISORS, LLC	-	-	-	-20,000	-100.00%	-	Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-21,400	-100.00%	-	Dec 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-27,629	-100.00%	-	Dec 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-28,156	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-31,900	-100.00%	-	Dec 31, 2023
BANK OF NEW YORK MELLON CORP	-	-	-	-40,367	-100.00%	-	Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-48,605	-100.00%	-	Dec 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	-	-	-	-53,080	-100.00%	-	Dec 31, 2023
NORTHERN TRUST CORP	-	-	-	-103,775	-100.00%	-	Dec 31, 2023
RFG ADVISORY, LLC	-	-	-	-250,000	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, Alzamend Neuro's largest institutional buyer is JPMORGAN CHASE & CO. The company purchased -49.00 stocks of ALZN, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TRUIST FINANCIAL CORP	-	-	-	-2,314,907	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-2,035,253	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-636,010	-100.00%	-	Dec 31, 2023
BLACKROCK INC.	-	-	-	-596,129	-100.00%	-	Dec 31, 2023
RFG ADVISORY, LLC	-	-	-	-250,000	-100.00%	-	Dec 31, 2023
NORTHERN TRUST CORP	-	-	-	-103,775	-100.00%	-	Dec 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	-	-	-	-53,080	-100.00%	-	Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-48,605	-100.00%	-	Dec 31, 2023
BANK OF NEW YORK MELLON CORP	-	-	-	-40,367	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-31,900	-100.00%	-	Dec 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-28,156	-100.00%	-	Dec 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-27,629	-100.00%	-	Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-21,400	-100.00%	-	Dec 31, 2023
FOUNDATIONS INVESTMENT ADVISORS, LLC	-	-	-	-20,000	-100.00%	-	Dec 31, 2023
XTX TOPCO LTD	-	-	-	-12,974	-100.00%	-	Dec 31, 2023
INSIGHT WEALTH STRATEGIES, LLC	-	-	-	-10,000	-100.00%	-	Dec 31, 2023
UBS GROUP AG	-	-	-	-7,927	-100.00%	-	Dec 31, 2023
IFP ADVISORS, INC	-	-	-	-5,000	-100.00%	-	Dec 31, 2023
HARBOR INVESTMENT ADVISORY, LLC	-	-	-	-3,000	-100.00%	-	Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-1,000	-100.00%	-	Dec 31, 2023

As of Dec 31 2023, Alzamend Neuro's biggest institutional seller is TRUIST FINANCIAL CORP. The company sold -2.31M shares of ALZN, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
TRUIST FINANCIAL CORP	-	-	-	-2,314,907	-100.00%	-	Dec 31, 2023
VANGUARD GROUP INC	-	-	-	-2,035,253	-100.00%	-	Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-636,010	-100.00%	-	Dec 31, 2023
BLACKROCK INC.	-	-	-	-596,129	-100.00%	-	Dec 31, 2023
RFG ADVISORY, LLC	-	-	-	-250,000	-100.00%	-	Dec 31, 2023
NORTHERN TRUST CORP	-	-	-	-103,775	-100.00%	-	Dec 31, 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	-	-	-	-53,080	-100.00%	-	Dec 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-48,605	-100.00%	-	Dec 31, 2023
BANK OF NEW YORK MELLON CORP	-	-	-	-40,367	-100.00%	-	Dec 31, 2023
STATE STREET CORP	-	-	-	-31,900	-100.00%	-	Dec 31, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-28,156	-100.00%	-	Dec 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-27,629	-100.00%	-	Dec 31, 2023
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-21,400	-100.00%	-	Dec 31, 2023
FOUNDATIONS INVESTMENT ADVISORS, LLC	-	-	-	-20,000	-100.00%	-	Dec 31, 2023
XTX TOPCO LTD	-	-	-	-12,974	-100.00%	-	Dec 31, 2023
INSIGHT WEALTH STRATEGIES, LLC	-	-	-	-10,000	-100.00%	-	Dec 31, 2023
UBS GROUP AG	-	-	-	-7,927	-100.00%	-	Dec 31, 2023
IFP ADVISORS, INC	-	-	-	-5,000	-100.00%	-	Dec 31, 2023
HARBOR INVESTMENT ADVISORY, LLC	-	-	-	-3,000	-100.00%	-	Dec 31, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-1,000	-100.00%	-	Dec 31, 2023
MORGAN STANLEY	-	-	-	-500	-100.00%	-	Dec 31, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-495	-100.00%	-	Dec 31, 2023
FMR LLC	-	-	-	-268	-100.00%	-	Dec 31, 2023
JPMORGAN CHASE & CO	-	-	-	-49	-100.00%	-	Dec 31, 2023

Alzamend Neuro's largest sold out institutional shareholder by shares sold is TRUIST FINANCIAL CORP, sold -2.31M shares, valued at -, as of undefined.

Alzamend Neuro Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD INDEX FUNDS	0.00%	2,035,253	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	511,605	-	-	Feb 29, 2024
SCHWAB CAPITAL TRUST	0.00%	53,080	-	-	Feb 29, 2024
Principal Exchange-Traded Funds	0.00%	9,846	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	49,644	-116	-0.23%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	78,545	-78,545	-50.00%	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	3,538	-	-	Feb 29, 2024
USAA MUTUAL FUNDS TRUST	0.00%	4,964	-	-	Jan 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	1,857	-	-	Mar 31, 2024

Alzamend Neuro's largest mutual fund holder by % of total assets is "VANGUARD INDEX FUNDS", owning 2.04M shares, compromising 0.00% of its total assets.

Alzamend Neuro Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Sep, 23	24	4.35%
30 Jun, 23	23	-23.33%
31 Mar, 23	30	-14.29%
31 Dec, 22	35	105.88%
30 Sep, 22	17	-29.17%
30 Jun, 22	24	-4.00%
31 Mar, 22	25	-10.71%
31 Dec, 21	28	16.67%
30 Sep, 21	24	140.00%
30 Jun, 21	10	-

As of 30 Sep 23, 24 institutions are holding Alzamend Neuro's shares, representing an increase of 4.35% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Sep, 23	6,248,424	1.95%
30 Jun, 23	6,128,982	-1.26%
31 Mar, 23	6,207,291	-10.82%
31 Dec, 22	6,960,481	-12.10%
30 Sep, 22	7,918,843	157.44%
30 Jun, 22	3,075,966	-5.09%
31 Mar, 22	3,240,856	327.42%
31 Dec, 21	758,242	17.56%
30 Sep, 21	644,973	118.17%
30 Jun, 21	295,635	-

Alzamend Neuro (ALZN) has 6.25M shares outstanding as of 30 Sep 23, up 1.95% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Sep, 23	6.35%	16.34%
30 Jun, 23	6.23%	15.64%
31 Mar, 23	6.31%	12.60%
31 Dec, 22	7.08%	10.73%
30 Sep, 22	8.12%	81.58%
30 Jun, 22	3.16%	23.85%
31 Mar, 22	3.64%	561.03%
31 Dec, 21	0.81%	169.08%
30 Sep, 21	0.69%	564.98%
30 Jun, 21	0.35%	-

As of 30 Sep 23, Alzamend Neuro is held by 6.35% institutional shareholders, representing a 16.34% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Sep, 23	11	120.00%
30 Jun, 23	5	-16.67%
31 Mar, 23	6	-71.43%
31 Dec, 22	21	162.50%
30 Sep, 22	8	-20.00%
30 Jun, 22	10	-33.33%
31 Mar, 22	15	-16.67%
31 Dec, 21	18	5.88%
30 Sep, 21	17	70.00%
30 Jun, 21	10	-

11 institutional shareholders have increased their position in ALZN stock as of 30 Sep 23 compared to 5 in the previous quarter (a 120.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Sep, 23	2	-60.00%
30 Jun, 23	5	-37.50%
31 Mar, 23	8	14.29%
31 Dec, 22	7	75.00%
30 Sep, 22	4	-33.33%
30 Jun, 22	6	-
31 Mar, 22	6	100.00%
31 Dec, 21	3	200.00%
30 Sep, 21	1	-
30 Jun, 21	-	-

2 institutional shareholders have reduced their position in ALZN stock as of 30 Sep 23 compared to 5 in the previous quarter (a -60.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Sep, 23	24	4.35%	6,248,424	1.95%	6.35%	16.34%	11	120.00%	2	-60.00%
30 Jun, 23	23	-23.33%	6,128,982	-1.26%	6.23%	15.64%	5	-16.67%	5	-37.50%
31 Mar, 23	30	-14.29%	6,207,291	-10.82%	6.31%	12.60%	6	-71.43%	8	14.29%
31 Dec, 22	35	105.88%	6,960,481	-12.10%	7.08%	10.73%	21	162.50%	7	75.00%
30 Sep, 22	17	-29.17%	7,918,843	157.44%	8.12%	81.58%	8	-20.00%	4	-33.33%
30 Jun, 22	24	-4.00%	3,075,966	-5.09%	3.16%	23.85%	10	-33.33%	6	-
31 Mar, 22	25	-10.71%	3,240,856	327.42%	3.64%	561.03%	15	-16.67%	6	100.00%
31 Dec, 21	28	16.67%	758,242	17.56%	0.81%	169.08%	18	5.88%	3	200.00%
30 Sep, 21	24	140.00%	644,973	118.17%	0.69%	564.98%	17	70.00%	1	-
30 Jun, 21	10	-	295,635	-	0.35%	-	10	-	-	-

Alzamend Neuro Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 14, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	75	$2.75	$206.25	77,268
Aug 01, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	25	$3.74	$93.42	77,193
Apr 23, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	1,000	$0.69	$688.20	771,699
Apr 03, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	334	$0.91	$304.24	770,699
Apr 01, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	2,000	$1.06	$2.13K	770,365
Mar 28, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	780,000	$1.20	$936.00K	2,000,000
Mar 28, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	780	$1.00	$780.00	2,000
Feb 02, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Sell	1,220,000	$1.20	$1.46M	1,220,000
Feb 02, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Sell	1,220	$1.00	$1.22K	1,220
Jan 09, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	5,000	$1.02	$5.09K	768,365
Dec 27, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	200	$0.92	$184.84	166,866
Dec 27, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	500	$0.90	$450.00	26,032
Sep 26, 2023	Katzoff David J	officer	Chief Financial Officer	P-Purchase	Buy	53,000	$0.19	$10.23K	81,000
May 26, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	18,000	$0.59	$10.70K	383,000
May 02, 2023	Jackman Stephan	director, officer	Chief Executive Officer	P-Purchase	Buy	37,000	$0.54	$20.00K	45,500
Mar 23, 2023	McGrath Lynne Fahey	director	-	P-Purchase	Buy	10,000	$0.43	$4.35K	10,000
Mar 20, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	5,000	$0.43	$2.15K	11,060,001

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 14, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	75	$2.75	$206.25	77,268
Aug 01, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	25	$3.74	$93.42	77,193
Apr 23, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	1,000	$0.69	$688.20	771,699
Apr 03, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	334	$0.91	$304.24	770,699
Apr 01, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	2,000	$1.06	$2.13K	770,365
Mar 28, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	780,000	$1.20	$936.00K	2,000,000
Mar 28, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	780	$1.00	$780.00	2,000
Jan 09, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	5,000	$1.02	$5.09K	768,365
Dec 27, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	200	$0.92	$184.84	166,866
Dec 27, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	500	$0.90	$450.00	26,032
Sep 26, 2023	Katzoff David J	officer	Chief Financial Officer	P-Purchase	Buy	53,000	$0.19	$10.23K	81,000
May 26, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	18,000	$0.59	$10.70K	383,000
May 02, 2023	Jackman Stephan	director, officer	Chief Executive Officer	P-Purchase	Buy	37,000	$0.54	$20.00K	45,500
Mar 23, 2023	McGrath Lynne Fahey	director	-	P-Purchase	Buy	10,000	$0.43	$4.35K	10,000
Mar 20, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	5,000	$0.43	$2.15K	11,060,001

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 16, 2024	McGrath Lynne Fahey	director	-		Sell	-	-	-	5,000
Feb 02, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Sell	1,220,000	$1.20	$1.46M	1,220,000
Feb 02, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Sell	1,220	$1.00	$1.22K	1,220
Jan 25, 2024	AULT MILTON C III	director, 10 percent owner		J-Other	Sell	661,168	-	-	5,498
Jan 25, 2024	AULT MILTON C III	director, 10 percent owner		J-Other	Sell	666,666	$45.00	$30.00M	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 14, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	75	$2.75	$206.25	77,268
Aug 01, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	25	$3.74	$93.42	77,193
May 16, 2024	McGrath Lynne Fahey	director	-		Sell	-	-	-	5,000
Apr 23, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	1,000	$0.69	$688.20	771,699
Apr 03, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	334	$0.91	$304.24	770,699
Apr 01, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	2,000	$1.06	$2.13K	770,365
Mar 28, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	780,000	$1.20	$936.00K	2,000,000
Mar 28, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	780	$1.00	$780.00	2,000
Feb 02, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Sell	1,220,000	$1.20	$1.46M	1,220,000
Feb 02, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Sell	1,220	$1.00	$1.22K	1,220
Jan 25, 2024	AULT MILTON C III	director, 10 percent owner		J-Other	Sell	661,168	-	-	5,498
Jan 25, 2024	AULT MILTON C III	director, 10 percent owner		J-Other	Sell	666,666	$45.00	$30.00M	-
Jan 09, 2024	AULT MILTON C III	director, 10 percent owner		P-Purchase	Buy	5,000	$1.02	$5.09K	768,365
Dec 27, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	200	$0.92	$184.84	166,866
Dec 27, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	500	$0.90	$450.00	26,032
Sep 26, 2023	Katzoff David J	officer	Chief Financial Officer	P-Purchase	Buy	53,000	$0.19	$10.23K	81,000
May 26, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	18,000	$0.59	$10.70K	383,000
May 02, 2023	Jackman Stephan	director, officer	Chief Executive Officer	P-Purchase	Buy	37,000	$0.54	$20.00K	45,500
Mar 23, 2023	McGrath Lynne Fahey	director	-	P-Purchase	Buy	10,000	$0.43	$4.35K	10,000
Mar 20, 2023	AULT MILTON C III	10 percent owner	-	P-Purchase	Buy	5,000	$0.43	$2.15K	11,060,001

The last insider sell of Alzamend Neuro's stock was made by McGrath Lynne Fahey on May 16 2024, selling - shares at - per share (valued at -). The last insider buy of ALZN was made by AULT MILTON C III on Aug 14 2024, buying 75 shares at $2.75 per share (worth $206.25).

Alzamend Neuro Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	1	-	-
Q2 2024	2	1	200.00%
Q1 2024	4	4	100.00%
Q4 2023	2	-	-
Q3 2023	1	-	-
Q2 2023	2	-	-
Q1 2023	5	1	500.00%
Q4 2022	13	-	-
Q3 2022	11	-	-
Q2 2022	17	2	850.00%
Q1 2022	13	7	185.71%
Q4 2021	19	7	271.43%
Q3 2021	62	8	775.00%
Q2 2021	23	17	135.29%
Q1 2021	-	-	-
Q2 2019	-	1	-

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Alzamend Neuro's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	1	-	-
Q2 2024	2	-	-
Q1 2024	6	-	-
Q4 2023	2	-	-
Q3 2023	1	-	-
Q2 2023	2	-	-
Q1 2023	4	-	-
Q4 2022	11	-	-
Q3 2022	11	-	-
Q2 2022	15	-	-
Q1 2022	8	3	266.67%
Q4 2021	14	2	700.00%
Q3 2021	57	1	5700.00%
Q2 2021	14	3	466.67%
Q1 2021	-	-	-
Q2 2019	-	-	-

As of Q3 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Alzamend Neuro's stocks.

Alzamend Neuro Peer Ownership

Ticker	Company
SNTI	Senti Biosciences, Inc.
XFOR	X4 Pharmaceuticals, Inc.
VECT	VectivBio Holding AG
DAWN	Day One Biopharmaceuticals, Inc.
HOOK	HOOKIPA Pharma Inc.
ALEC	Alector, Inc.
TERN	Terns Pharmaceuticals, Inc.
INZY	Inozyme Pharma, Inc.
ADVM	Adverum Biotechnologies, Inc.
ABOS	Acumen Pharmaceuticals, Inc.
SLDB	Solid Biosciences Inc.
ADAG	Adagene Inc.
MOLN	Molecular Partners AG
KZR	Kezar Life Sciences, Inc.

ALZN Ownership FAQ

Who Owns Alzamend Neuro?

Alzamend Neuro is owned by institutional shareholders (6.35%), insiders (24.22%), and public (69.43%). The largest institutional shareholder of Alzamend Neuro is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is VANGUARD INDEX FUNDS (0.00% of total shares).

Who are the major institutional shareholders of Alzamend Neuro?

Alzamend Neuro's major institutional shareholders are JPMORGAN CHASE & CO, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, TRUIST FINANCIAL CORP, and STATE STREET CORP. The top five shareholders own together 0% of the company's share outstanding.

How many Alzamend Neuro shareholders are there?

As of Sep 2023, there are 24 institutional shareholders of Alzamend Neuro.

What percentage of Alzamend Neuro is owned by JPMORGAN CHASE & CO?

JPMORGAN CHASE & CO owns 0 shares of Alzamend Neuro, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).

What percentage of Alzamend Neuro is owned by WELLS FARGO & COMPANY/MN?

As of Dec 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Alzamend Neuro (ALZN), compromising 0% of the company, valued at $0.

What percentage of Alzamend Neuro is owned by NORTHERN TRUST CORP?

NORTHERN TRUST CORP is the third largest holder of Alzamend Neuro. The company owns 0 of the company's shares outstanding (worth $0).